--- title: "Brink’s Delivers Strong Q1 Growth and Margin Expansion" type: "News" locale: "en" url: "https://longbridge.com/en/news/285371204.md" description: "Brink’s Company (BCO) reported a strong Q1 with a 10% revenue increase to $1.38 billion, driven by 4.5% organic growth and 15% in higher-margin AMS and DRS lines. Adjusted EBITDA rose 10%, and free cash flow exceeded $500 million. Despite a decline in GAAP net income, Brink’s highlighted margin expansion and a 2026 growth framework. The planned acquisition of NCR Atleos is on track, aiming for $200 million in annual cost synergies. Analysts rate BCO as a Buy with a $145 price target, while Spark’s AI Analyst gives it a Neutral rating due to risks from leverage and execution." datetime: "2026-05-06T11:44:21.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285371204.md) - [en](https://longbridge.com/en/news/285371204.md) - [zh-HK](https://longbridge.com/zh-HK/news/285371204.md) --- # Brink’s Delivers Strong Q1 Growth and Margin Expansion ### Claim 55% Off TipRanks - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Brink’s Company ( (BCO) ) has issued an update. On May 6, 2026, Brink’s reported a strong first quarter, with revenue rising 10% year over year to $1.38 billion, including 4.5% organic growth and 15% organic growth in its higher-margin AMS and DRS lines, while adjusted EBITDA climbed 10% and free cash flow continued to improve, pushing trailing 12-month free cash flow above $500 million. Despite a decline in GAAP net income and operating profit, Brink’s highlighted margin expansion on a non-GAAP basis, detailed a 2026 framework targeting mid-single-digit organic revenue growth, mid-to-high-teens AMS/DRS growth, and higher EBITDA margins, and said its planned acquisition of NCR Atleos remained on track to close by the end of the first quarter of 2027, with a dedicated team preparing to capture $200 million in annual cost synergies. The most recent analyst rating on (BCO) stock is a Buy with a $145.00 price target. To see the full list of analyst forecasts on Brink’s Company stock, see the BCO Stock Forecast page. **Spark’s Take on BCO Stock** According to Spark, TipRanks’ AI Analyst, BCO is a Neutral. BCO scores in the high-50s primarily due to solid revenue/profitability improvement and consistently positive (recently stronger) free cash flow, offset by a highly leveraged balance sheet that raises risk. Technical indicators are neutral-to-weak, while valuation is only moderate with a low dividend yield. Corporate events add upside potential via the proposed NCR Atleos deal, but they also increase execution/financing risk. To see Spark’s full report on BCO stock, click here. **More about Brink’s Company** The Brink’s Company, listed on the NYSE as BCO and headquartered in Richmond, Va., is a leading global provider of cash and valuables management, digital retail solutions and ATM managed services. The company focuses on higher-margin businesses such as ATM outsourcing, technology-enabled cash management and digital solutions for retailers and financial institutions worldwide. **Average Trading Volume:** 513,144 **Technical Sentiment Signal:** Buy **Current Market Cap:** $4.29B ### Related Stocks - [BCO.US](https://longbridge.com/en/quote/BCO.US.md) ## Related News & Research - [Brink's (NYSE:BCO) Announces Quarterly Earnings Results](https://longbridge.com/en/news/285648409.md) - [Brink’s Shareholders Approve Expanded Equity Incentive Plan](https://longbridge.com/en/news/285126316.md) - [Does Slower Organic Growth Undermine the Automation and M&A Story at Applied Industrial Technologies (AIT)?](https://longbridge.com/en/news/286647498.md) - [22:13 ETGLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit](https://longbridge.com/en/news/286842370.md) - [Stellantis N.V. (STLA) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit](https://longbridge.com/en/news/286607688.md)